# OnCo record aptadir-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/aptadir-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "aptadir-therapeutics" ;
  schema:name "AptaDir Therapeutics"@en ;
  schema:alternateName "Aptadir"@en ;
  schema:description "AptaDir Therapeutics is developing short RNA medicines that switch back on genes a cancer has silenced, by blocking the enzyme that adds the chemical tags which turn those genes off. Its first candidate is for myelodysplastic syndromes, a group of bone marrow cancers, and was preclinical in 2024."@en ;
  schema:url <https://onco.cc/companies/aptadir-therapeutics/>, <https://aptadir.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://aptadir.com/>, <https://aptadir.com/wp-content/uploads/2024/09/Aptadir-Press-Release-24092024.pdf>, <https://aptadir.com/projects/> ;
  schema:addressCountry "IT" ;
  onco:cancers <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/epigenetics/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> .